Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Colorcon
Baxter
AstraZeneca
Mallinckrodt

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

West-ward Pharms Int Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has two hundred and eight approved drugs.

There are two tentative approvals on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int
US Patents:0
Tradenames:142
Ingredients:127
NDAs:208

Drugs and US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075567-001 Mar 29, 2001 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int BLEOMYCIN SULFATE bleomycin sulfate INJECTABLE;INJECTION 065042-001 Oct 17, 2001 AP RX No No   Start Trial   Start Trial
West-ward Pharms Int PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 089475-001 Nov 5, 1986 DISCN No No   Start Trial   Start Trial
West-ward Pharms Int NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070496-001 Sep 24, 1986 DISCN No No   Start Trial   Start Trial
West-ward Pharms Int NALOXONE naloxone hydrochloride INJECTABLE;INJECTION 070298-001 Sep 24, 1986 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for West-ward Pharms Int

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 3,947,569   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 3,947,569   Start Trial
West-ward Pharms Int REGLAN metoclopramide hydrochloride INJECTABLE;INJECTION 017862-004 May 28, 1987 4,536,386   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-003 Sep 30, 1982 4,110,438   Start Trial
West-ward Pharms Int FACTREL gonadorelin hydrochloride INJECTABLE;INJECTION 018123-001 Sep 30, 1982 4,110,438   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
Baxter
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.